iih glp-1 Novel use of receptor agonist therapy for pediatric idiopathic intracranial hypertension: a case report JAMA - Most viewed this

On the heels of As of Monday January 5, 2026, patients will have access to the starter dose of the oral GLP-1, 1.5 mg, with additional strengths reported to be released by the end of the week

Rocio Salas Whalen It may surprise you to learn that these medications arent new

Just two capsules daily good for your healthy digestion and nutrient absorption Overall Metabolic Health: Specifically developed for women's metabolic health, this GLP-1 supplement good for mitochondrial function and helps optimize your metabolism

Exenatide (Byetta), approved by the FDA on April 28, 2005, for type 2 diabetes

Lower socioeconomic status correlated with an increased risk of early-onset dementia, particularly pronounced in T2DM patients (Li R

The digestive changes caused by GLP-1 medications may also affect how efficiently the body processes certain foods, which could contribute to the development of sulphur-smelling burps in some patients